Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Thalys Medical Technology Group's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Thalys Medical Technology Group's Dividend Payout Ratio or its related term are showing as below:
During the past 13 years, the highest Dividend Payout Ratio of Thalys Medical Technology Group was 0.27. The lowest was 0.05. And the median was 0.08.
SHSE:603716's Dividend Payout Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.49 * Ranked among companies with meaningful Dividend Payout Ratio only.
During the past 13 years, the highest Trailing Annual Dividend Yield of Thalys Medical Technology Group was 0.63%. The lowest was 0.00%. And the median was 0.23%.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Thalys Medical Technology Group was 51.50% per year. The lowest was 51.50% per year. And the median was 51.50% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Thalys Medical Technology Group (SHSE:603716) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thalys Medical Technology Group Dividend Payout Ratio Related Terms
Thalys Medical Technology Group Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thalys Medical Technology Group Dividend Payout Ratio Chart
SHSE:603716 vs TMO, DHR, IDXX: Dividend Payout Ratio Comparison
For the Diagnostics & Research subindustry, Thalys Medical Technology Group's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thalys Medical Technology Group Dividend Payout Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Thalys Medical Technology Group's Dividend Payout Ratio falls into.
Thalys Medical Technology Group Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thalys Medical Technology Group (SHSE:603716) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Thalys Medical Technology Group and its competitors. Over the past decade, Thalys Medical Technology Group's Dividend Payout Ratio has ranged from 0.05 to 0.27. According to the industry distribution chart, Thalys Medical Technology Group ranks #999999 out of 54 companies in the Medical Diagnostics & Research industry.
Is Thalys Medical Technology Group's Dividend Payout Ratio too high?
Thalys Medical Technology Group's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.27. Based on the distribution chart, Thalys Medical Technology Group ranks #999999 out of 54 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Thalys Medical Technology Group has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Thalys Medical Technology Group's Dividend Payout Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Thalys Medical Technology Group ranks #999999 out of 54 companies for Dividend Payout Ratio. This places Thalys Medical Technology Group in the lower half of its industry. The industry median Dividend Payout Ratio is 0.49. Historically, Thalys Medical Technology Group's own Dividend Payout Ratio has ranged from 0.05 to 0.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Diagnostics & Research company?
The median Dividend Payout Ratio among Medical Diagnostics & Research companies is 0.49, based on 54 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Thalys Medical Technology Group and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Payout Ratio is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thalys Medical Technology Group's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thalys Medical Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Thalys Medical Technology Group (SHSE:603716) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.70, compared to a current price of ¥15.89 — trading 238.1% above its estimated fair value. The current Dividend Payout Ratio is 0.00. Thalys Medical Technology Group's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Thalys Medical Technology Group (SHSE:603716), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thalys Medical Technology Group (SHSE:603716) Overvalued in 2026?
Based on GuruFocus' analysis, Thalys Medical Technology Group stock appears to be overvalued.
The current stock price of ¥15.89 is trading 238.1% above its estimated GF Value™ of ¥4.70.
GuruFocus considers Thalys Medical Technology Group to be Significantly Overvalued.
Key valuation signals for SHSE:603716:
Dividend Payout Ratio: 0.00
GF Value™: ¥4.70 vs. price of ¥15.89 (238.1% above fair value)
No single metric tells the full story. See the SHSE:603716 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
39GF Score
Get the complete analysis for SHSE:603716
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603716 has been successfully added to your 
